Yumanity Therapeutics

Yumanity's end: J&J pays $26M for neuroscience assets as reverse merger erases biotech
Fierce Biotech
Mon, 06/6/22 - 10:29 am
Yumanity Therapeutics
JNJ
Kineta
Merck
M&A
Tony Coles takes second neuroscience startup public as Yumanity reverse merges
Endpoints
Mon, 08/24/20 - 10:17 am
Tony Coles
Cerevel
Yumanity Therapeutics
cystic fibrosis
Proteostasis Therapeutics
Yumanity and Merck Ink $500 Million+ Deal for Neurodegenerative Diseases
BioSpace
Wed, 06/24/20 - 10:28 am
Yumanity Therapeutics
Merck
ALS
frontotemporal lobar dementia
R&D
Gloomy results from the research for an Alzheimer’s therapy
GoinPharma
Thu, 11/30/17 - 09:54 am
Alzheimer's disease
Merck
Eli Lilly
Lundbeck
Biogen
Denali Therapeutics
Yumanity Therapeutics
drug development
Fidelity, Biogen, Sanofi Join $45M Bet On Alzheimer's And Parkinson's Startup
Forbes
Wed, 02/10/16 - 09:47 am
Biogen
Sanofi
Alzheimer's disease
Parkinson's Disease
Yumanity Therapeutics
The 2015 Fierce 15 biotech execs take a bow
Fierce Biotech
Sat, 10/3/15 - 02:01 pm
Alector
Arvinas
CRISPR Therapeutics
Intellia Therapeutics
NGM Biopharmaceuticals
Padlock Therapeutics
SQZ Biotech
Revolution Medicines
Syros Pharmaceuticals
Unum Therapeutics
Yumanity Therapeutics
FierceBiotech's 2015 Fierce 15
Fierce Biotech
Wed, 09/30/15 - 09:51 am
Alector
Arvinas
Cell Medica
CRISPR Therapeutics
Denali Therapeutics
Intellia Therapeutics
MyoKardia
NGM Biopharmaceuticals
Padlock Therapeutics
Revolution Medicines SQZ Biotech
Surface Oncology
Syros Pharmaceuticals
Unum Therapeutics
Yumanity Therapeutics
The Coming Boom In Brain Medicines
Forbes
Wed, 02/11/15 - 09:33 am
Yumanity Therapeutics
SAGE Therapeutics
Acadia
Naurex
brain research
Former Onyx CEO Returns to Biotech to Launch Boston Start Up
TheStreet.com
Mon, 12/15/14 - 10:45 am
Tony Coles
ONYX Pharmaceuticals
Yumanity Therapeutics